The ‘Rebate Rule’ Reborn? US Senate Bill Would Test Price Pass-Throughs

 
• By Michael McCaughan

A plan to ban rebates in the US Medicare outpatient drug program was a signature policy proposal of the Trump Administration – but has never been implemented. A Senate bill tests a different approach to the same goal of ensuring that price concessions by manufacturers translate into lower prices charged at the pharmacy counter.

US capitol watercolor reflection
If enacted, the legislation will give stakeholders a chance to reflect on the impact of Trump-era policy proposals. • Source: Shutterstock

More from Market Access

More from Pink Sheet